Details for Patent: 8,945,516
✉ Email this page to a colleague
Which drugs does patent 8,945,516 protect, and when does it expire?
Patent 8,945,516 protects AMZEEQ and ZILXI and is included in two NDAs.
This patent has twenty-two patent family members in ten countries.
Summary for Patent: 8,945,516
| Title: | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| Abstract: | A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition. |
| Inventor(s): | Tamarkin; Dov (Ness Ziona, IL), Gazal; Elana (Rehovot, IL), Papiashvili; Irakliy (Askelon, IL), Hazot; Yohan (Rehovot, IL), Schuz; David (Moshav, IL), Keynan; Rita (Rehovot, IL) |
| Assignee: | Foamix Pharmaceuticals Ltd. (Rehovot, IL) |
| Application Number: | 13/499,501 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,945,516 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 8,945,516
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Journey | ZILXI | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 213690-001 | May 28, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,945,516
| PCT Information | |||
| PCT Filed | October 01, 2010 | PCT Application Number: | PCT/IB2010/002612 |
| PCT Publication Date: | April 07, 2011 | PCT Publication Number: | WO2011/039637 |
International Family Members for US Patent 8,945,516
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010302350 | ⤷ Try a Trial | |||
| Australia | 2015224534 | ⤷ Try a Trial | |||
| Brazil | 112012007473 | ⤷ Try a Trial | |||
| Canada | 2776366 | ⤷ Try a Trial | |||
| Canada | 2776471 | ⤷ Try a Trial | |||
| Canada | 2776474 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
